-
公开(公告)号:PE16922009A1
公开(公告)日:2009-11-07
申请号:PE0003652009
申请日:2009-03-12
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , VERBEUREN TONY , RUPIN ALAIN , LEFOULON FRANCOIS , BOUSSARD MARIE-FRANCOISE , SANSILVESTRI-MOREL PATRICIA , PAYSANT JEROME
IPC: A61K31/352 , A61P7/00 , A61P7/02 , A61P9/00 , A61P9/10 , C07D311/30 , C07D407/02 , C07D407/12 , C07D407/14
CPC classification number: C07D311/30 , C07D407/12 , C07H15/203 , C07H17/07
Abstract: REFERIDA A UN COMPUESTO DERIVADO DE DIOSMETINA DE FORMULA (I), DONDE R1, R2 Y R3 SON UN ATOMO DE H O EL GRUPO (A). SON COMPUESTOS PREFERIDOS: 6,8,2'-TRIS-(ISOBUT-2-EN-1-IL)DIOSMETINA, ACIDO (5-HIDROXI-2-[3-HIDROXI-4-METOXI-2-(ISOBUT-2-EN-1-IL)FENIL]-6,8-BIS(ISOBUT-2-EN-1-IL)-4-OXO-4H-CROMEN-7-IL)BETA-D-GLUCURONICO, ACIDO 3-[5,7-DIHIDROXI-6,8-BIS(ISOBUT-2-EN-1-IL)-4-OXO-4H-CROMEN-2-IL]6-METOXI-2-(ISOBUT-2-EN-1-IL)FENIL BETA-D-GLUCURONICO. TAMBIEN ESTA REFERIDA A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LAS MOLECULAS DE ADHESION, INHIBIDORES DE LA NADPH OXIDASA Y ANTIAGREGANTES PLAQUETARIOS Y SON UTILES EN EL TRATAMIENTO DEL SINDROME POST-TROMBOTICO, ENFERMEDADES VENOSAS, COMPLICACIONES VASCULARES LIGADAS A DIABETES, HIPERTENSION, ATEROSCLEROSIS, INFLAMACION, SINDROME METABOLICO LIGADO A LA OBESIDAD, ENTRE OTROS
-
公开(公告)号:SV2009003199A
公开(公告)日:2009-10-27
申请号:SV2009003199
申请日:2009-03-30
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , VERBEUREN TONY , SANSILVESTRI-MOREL PATRICIA , RUPIN ALAIN , PAYSANT JEROME , LEFOULON FRANCOISE
Abstract: COMPUESTOS DE FORMULA (I): (VER FORMULA); EN LA QUE R1, R2 Y R3, IDÉNTICOS O DIFERENTES, REPRESENTAN CADA UNO UN ÁTOMO DE HIDROGENO O EL GRUPO DE FORMULA (A): (VER FORMULA); MEDICAMENTOS
-
公开(公告)号:CA2389766C
公开(公告)日:2007-09-25
申请号:CA2389766
申请日:2002-06-13
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , GUILBAUD NICOLAS , LEONCE STEPHANE , BOUSSARD MARIE-FRANCOISE , PIERRE ALAIN , HICKMAN JOHN , ATASSI GHANEM , ROUSSEAU ANNE , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/56 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056
Abstract: L'invention concerne de nouveaux composés répondant à la formule (I) : dans laquelle R représente un atome d'hydrogène ou un groupement alkyle éventuellement substitué ou alkényle; R1 à R8, identiques ou différents, représentent chacu n un atome d'hydrogène ou un groupement alkyle éventuellement substitué, hydroxy, acyloxy, amino éventuellement subsitué, carboxy, alkoxy éventuellement subsitué ou alkényloxy, ou bien l'un des groupements R1 à R8 forme avec un autre groupement R1 à R8 contigu un groupement alkylènedioxy; X représente un atome d'oxygène ou un groupement NR16 dans lequel R16 représente un atome d'hydrogène ou un groupement alkyle, ary le ou arylalkyle; et R9 représente un atome d'hydrogène, un groupement aryle ou hétéroaryle ou un groupement alkyle saturé ou insaturé, éventuellement substitué. L'inventi on vise également les isomères des composés de formule (I), ainsi que leurs sels d'addition à un acide ou à une base pharmaceutiquement acceptable. Les composés selon l'invention sont utiles comme médicaments pour le traitement de cancers.
-
公开(公告)号:AR053149A1
公开(公告)日:2007-04-25
申请号:ARP060100756
申请日:2006-03-01
Applicant: SERVIER LAB
Inventor: VERBEUREN TONY , RUPIN ALAIN , SANSILVESTRI-MOREL PATRICIA , VALLEZ MARIE-ODILE , BOUSSARD MARIE-FRANCOISE , WIERZBICKI MICHEL
IPC: A61K31/352 , A61P7/02
Abstract: Uso de compuestos de diosmetina para la obtencion de composiciones farmacéuticas destinadas a la prevencion y/o tratamiento de patologías tromboticas y patologías que conlleven el riesgo de producir trombosis Reivindicacion 1:Utilizacion de compuestos de diosmetina de formula (1) caracterizado porque: R1 representa un átomo de hidrogeno o un radical propilo o alilo; R2 representa un átomo de hidrogeno o un radical propilo, alilo, 2,3-dihidroxipropilo, (2,2-dimetil-1,3-dioxol-4- il)metilo o 3-acetiloxi-2-hidroxipropilo; R3 representa un átomo de hidrogeno o un radical propilo o alilo; R4 representa un átomo de hidrogeno o un radical, metilo, propilo, alilo, 2,3-dihidroxipropilo o (2,2-dimetil-1,3-dioxol-4-il)metilo o un radical de formula -COR'4 donde R'4 representa un radical alquilo (C1-C5) lineal o ramificado o un radical fenilo: -R5 representa un átomo de hidrogeno o un radical propilo o alilo; y R6 representa un átomo de hidrogeno o un radical metilo, propilo, alilo, 2,3-dihidroxipropil o (2,2-dimetil-1,3-dioxol-4-il)metilo, un radical de formula -COR'6 (donde R6 representa un radical alquilo (C1-C5( lineal o ramificado o un radical fenilo) o un radical de formula (I'): proveyéndose que; al menos uno de los grupos R1, R2, R3, R4, R5 y R6 no es un átomo de hidrogeno, y si cada uno de R1, R2 y R3 representa simultáneamente un átomo de hidrogeno, R4 representa también un átomo de hidrogeno, R4 representa también un átomo de hidrogeno, sus diastereoisomeros y enantiomeros, y asimismo sus sales de adicion con un ácido o base farmacéuticamente aceptable en la obtencion de composiciones farmacéuticas destinadas a la prevencion y/o tratamiento de patologías tromboticas.
-
公开(公告)号:DE60201296T2
公开(公告)日:2006-02-23
申请号:DE60201296
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:DK1266887T3
公开(公告)日:2005-10-31
申请号:DK02291463
申请日:2002-06-12
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , ATASSI GHANEM , LEONCE STEPHANE , GUILBAUD NICOLAS , HICKMAN JOHN , PIERRE ALAIN , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056 , A61K31/404 , A61K31/407 , A61K31/44 , A61K31/445
Abstract: Indenoindolone derivatives (I), their isomers and salts with acids and bases are new. Indenoindolone derivatives (I), their isomers and salts with acids and bases are new; R = H, alkyl (optionally substituted by carboxy, alkoxycarbonyl, or NR10R11), or alkenyl; R1-R8 = H, alkyl (optionally substituted by aryl, carboxy or alkoxycarbonyl), OH, acyloxy, NR12R13, carboxy, alkoxy (optionally substituted by aryl or NR14R15), alkenyloxy, or to adjacent groups R1-R8 = 1 or 2C alkylenedioxy; R9 = H, aryl, heteroaryl or alkyl (optionally containing one or more unsaturations and optionally substituted by one or more aryl, heteroaryl, 3-8C cycloalkyl, CN, or NR17R18 groups); X = O or NR16; R10, R11, R14, R15, R17, R18 = alkyl; NR10+R11, NR14+R15, NR17+R18 = nitrogen heterocycle; R12, R13 = H, alkyl, or NR14R15; R16 = H, alkyl, aryl, or aryl alkyl. Where alkyl, alkoxy, acyloxy, alkenyl and alkenyloxy groups have up to 6 C atoms, aryl is defined as phenyl, biphenyl, or naphthyl (optionally substituted by one or more halogen, alkyl, alkenyl, alkoxy, phenoxy, nitro, CN, amino, mono- and di-alkylamino or 1-2C alkylenedioxy groups) and heteroaryl groups may be mono- or bicyclic of 5-12 members with 1-3 heteroatoms (O, N, S) and optionally substituted by halogen, alkyl, OH, alkoxy, polyhaloalkyl, amino, mono- and di-alkylamino groups, and nitrogen heterocycles are monocyclic having 5-7 members including 1-3 heteroatoms, one of which is N and the others may be O, N, or S. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:AT277027T
公开(公告)日:2004-10-15
申请号:AT02291501
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
88.
公开(公告)号:EA004571B1
公开(公告)日:2004-06-24
申请号:EA200200563
申请日:2002-06-13
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , ATASSI GHANEM , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE , GUILBAUD NICOLAS , KRAUS-BERTHIER LAURENCE
IPC: C07D209/80 , A61K31/403 , A61K31/433 , A61K31/4439 , A61P35/00 , C07D209/94 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D491/04 , C07D491/056 , C07D209/58 , C07D491/08 , A61K31/407
Abstract: Соединениеформулы (I)вкоторой R представляетсобойатомводорода, необязательнозамещеннуюалкильнуюгруппуилиалкенильнуюгруппу, от Rдо R, которыемогутбытьодинаковыилиразличны, каждыйпредставляетсобойатомводородаилинеобязательнозамещеннуюалкильнуюгруппу, гидроксигруппу, необязательнозамещеннуюаминогруппу, карбоксигруппу, необязательнозамещеннуюалкоксигруппу, илиоднаизгруппот Rдо Rобразуетс другойизгруппот Rдо R, котораянаходитсярядом, алкилендиоксигруппу, X представляетсобойатомкислородаилигруппу NR, вкоторой Rпредставляетсобойатомводорода, алкильную, арильнуюилиаралкильнуюгруппу, Rпредставляетсобойатомводорода, арильнуюгруппу, гетероарильнуюгруппуилинеобязательнозамещенную, насыщеннуюилиненасыщеннуюалкильнуюгруппу, ихизомеры, атакжеихаддитивныесолис фармацевтическиприемлемойкислотойилиоснованием. Лекарственныепрепараты.
-
公开(公告)号:DK1245565T3
公开(公告)日:2004-01-12
申请号:DK02290668
申请日:2002-03-18
Applicant: SERVIER LAB
Inventor: ROUSSEAU ANNE , WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D491/056 , A61K31/40 , A61K31/403 , A61K31/407 , A61K31/5377 , A61P3/04 , A61P3/10 , A61P5/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/28 , A61P35/00 , A61P43/00 , C07D209/80 , C07D209/94
Abstract: Compound of formula (I):wherein:R represents hydrogen or a group selected from alkenyl and optionally substituted alkyl,each of R1 to R8, which may be identical or different, represents hydrogen or a group selected from alkyl, alkenyl, hydroxy, alkoxy, alkenyloxy, arylalkyl, arylalkoxy, carboxy, acyloxy and arylcarbonyloxy,or one of R1 to R8 forms with an adjacent one R1 to R8 an alkylenedioxy group,its optical isomers when they exist, and addition salts thereof with a pharmaceutically acceptable acid or base,with the proviso that:when R does not represent hydrogen, then at least one of R1 to R8 represents hydroxy or acyloxy,and the compounds of formula (I) are other than indeno[1,2-b]indol-10(5H)-one and medicinal products containing the same which are useful for treatment of disorders of the melatoninergic system.
-
90.
公开(公告)号:SI1241169T1
公开(公告)日:2003-12-31
申请号:SI200230002
申请日:2002-03-11
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , BOUSSARD MARIE-FRANCOISE , ROUSSEAU ANNE , BOUTIN JEAN-ALBERT , DELAGRANGE PHILIPPE
IPC: C07D487/06 , A61K31/407 , A61P3/04 , A61P3/10 , A61P9/00 , A61P15/00 , A61P25/00 , A61P25/04 , A61P25/16 , A61P25/18 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/28 , A61P35/00 , A61P43/00 , C07D487/04
Abstract: Compound of formula (I):wherein:R1, R2, R3, R4, R5, R6 and R8, which may be identical or different, each represents hydrogen, alkyl, arylalkyl, hydroxy, alkoxy, arylalkoxy, acyloxy, arylcarbonyloxy, carboxyalkyl or carboxy,R7 represents hydrogen, hydroxy, alkoxy, arylalkoxy, acyloxy or arylcarbonyloxy group,or one of R1 to R8, together with another of R1 to R8 adjacent to it, forms an alkylenedioxy,its optical isomers, and addition salts thereof with a pharmaceutically acceptable acid or base.
-
-
-
-
-
-
-
-
-